The FinTech Hub
Source: Live Mint Shares of pharma major Lupin rebounded from their day’s low after the company posted strong financial results for the quarter ended December 2024 (Q3 FY25). The stock initially fell by 3.2 percent to an intra-day low of ₹2,000.10 in early trade but later recovered by almost 6 percent, reaching day’s high of…
Source: Live Mint Nifty 50 on 6 February Nifty 50 closed 93 points lower at 23,603.35 on Thursday, a day ahead of the outcome of the Reserve Bank of India’s (RBI) monetary policy meeting, where expectations point to a 25 basis points repo rate cut to 6.25%. The index had opened on a positive note…
Source: Live Mint Two stocks to trade, recommended by NeoTrader’s Raja Venkatraman: • Ester Industries Ltd: Buy above ₹169 | Target ₹185 | Stop loss ₹162 This counter, after testing the value support region around ₹136-138 levels in the last few weeks, has shown an inclination to resume the upward bounce. A long body candle…
Source: Live Mint The big day is here! FM Sitharaman will deliver her 8th Budget speech at 11 a.m. Even though it’s a Saturday, stock markets (BSE and NSE) will remain open. This will be her second full Budget under Modi 3.0 and her eighth overall, including six annual and two interim Budgets during the…
Source: Live Mint Recent high-frequency economic data highlights the persistent macroeconomic challenges in India, including subdued GST collection growth, fluctuating automobile sales, and currency volatility, according to InCred. These factors have contributed to cautious market sentiment, with the Nifty 50 index likely to remain in a consolidation phase due to prolonged risks to GDP and…
Source: Live Mint Nifty 50 on 30 December: Recap Benchmark indices fell on the penultimate trading day of 2024, dragged down by losses in banking stocks amid weak global cues. Most global markets traded weak as elevated US treasury yields and the prospect of fewer US rate cuts than earlier anticipated weighed on sentiment. Nifty…
Source: Business Standard 4 min read Last Updated : Sep 16 2024 | 11:02 AM IST The Indian pharmaceutical giants are taking a halt in filing new drug applications, with new filings lowest in the past 19 years, says a latest report by Japanese brokerage firm, Nomura. However, this is not concerning the…
